338 related articles for article (PubMed ID: 10559324)
1. Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA.
Yamano S; Tokino T; Yasuda M; Kaneuchi M; Takahashi M; Niitsu Y; Fujinaga K; Yamashita T
J Virol; 1999 Dec; 73(12):10095-103. PubMed ID: 10559324
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
[TBL] [Abstract][Full Text] [Related]
3. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
[TBL] [Abstract][Full Text] [Related]
4. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
5. The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex.
Obert S; O'Connor RJ; Schmid S; Hearing P
Mol Cell Biol; 1994 Feb; 14(2):1333-46. PubMed ID: 8289811
[TBL] [Abstract][Full Text] [Related]
6. Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein.
Schaley J; O'Connor RJ; Taylor LJ; Bar-Sagi D; Hearing P
J Virol; 2000 Mar; 74(5):2084-93. PubMed ID: 10666238
[TBL] [Abstract][Full Text] [Related]
7. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
Nevins JR
Science; 1992 Oct; 258(5081):424-9. PubMed ID: 1411535
[TBL] [Abstract][Full Text] [Related]
8. Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein.
Nevels M; Rubenwolf S; Spruss T; Wolf H; Dobner T
J Virol; 2000 Jun; 74(11):5168-81. PubMed ID: 10799592
[TBL] [Abstract][Full Text] [Related]
9. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.
Veal E; Eisenstein M; Tseng ZH; Gill G
Mol Cell Biol; 1998 Sep; 18(9):5032-41. PubMed ID: 9710587
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
Swaminathan S; Thimmapaya B
J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
[TBL] [Abstract][Full Text] [Related]
11. Transforming potential of the adenovirus type 5 E4orf3 protein.
Nevels M; Täuber B; Kremmer E; Spruss T; Wolf H; Dobner T
J Virol; 1999 Feb; 73(2):1591-600. PubMed ID: 9882365
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
Wong HK; Ziff EB
J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic potential of the adenovirus E4orf6 protein.
Moore M; Horikoshi N; Shenk T
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11295-301. PubMed ID: 8876129
[TBL] [Abstract][Full Text] [Related]
15. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.
Hiebert SW
Mol Cell Biol; 1993 Jun; 13(6):3384-91. PubMed ID: 8497257
[TBL] [Abstract][Full Text] [Related]
16. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
[TBL] [Abstract][Full Text] [Related]
17. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein.
Helin K; Harlow E
J Virol; 1994 Aug; 68(8):5027-35. PubMed ID: 8035503
[TBL] [Abstract][Full Text] [Related]
18. Rb may act as a transcriptional co-activator in undifferentiated F9 cells.
Bocco JL; Reimund B; Chatton B; Kedinger C
Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500
[TBL] [Abstract][Full Text] [Related]
19. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis.
Marcellus RC; Lavoie JN; Boivin D; Shore GC; Ketner G; Branton PE
J Virol; 1998 Sep; 72(9):7144-53. PubMed ID: 9696808
[TBL] [Abstract][Full Text] [Related]
20. The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Enhances E1A Functional Activity.
Dallaire F; Schreiner S; Blair GE; Dobner T; Branton PE; Blanchette P
mSphere; 2016; 1(1):. PubMed ID: 27303687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
